M&T Bank’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-89,280
| Closed | -$134K | – | 1598 |
|
|
2023
Q1 | $134K | Sell |
89,280
-59,042
| -40% | -$88.9K | ﹤0.01% | 1533 |
|
|
2022
Q4 | $370K | Buy |
148,322
+87,790
| +145% | +$219K | ﹤0.01% | 1218 |
|
|
2022
Q3 | $256K | Buy |
60,532
+8,810
| +17% | +$37.3K | ﹤0.01% | 1335 |
|
|
2022
Q2 | $144K | Buy |
51,722
+26,870
| +108% | +$74.8K | ﹤0.01% | 1425 |
|
|
2022
Q1 | $142K | Buy |
24,852
+2,064
| +9% | +$11.8K | ﹤0.01% | 1406 |
|
|
2021
Q4 | $208K | Buy |
22,788
+1,243
| +6% | +$11.3K | ﹤0.01% | 1436 |
|
|
2021
Q3 | $230K | Hold |
21,545
| – | – | ﹤0.01% | 1370 |
|
|
2021
Q2 | $334K | Hold |
21,545
| – | – | ﹤0.01% | 1215 |
|
|
2021
Q1 | $349K | Buy |
21,545
+2,463
| +13% | +$39.9K | ﹤0.01% | 1173 |
|
|
2020
Q4 | $404K | Hold |
19,082
| – | – | ﹤0.01% | 1169 |
|
|
2020
Q3 | $282K | Buy |
19,082
+4,206
| +28% | +$62.2K | ﹤0.01% | 1267 |
|
|
2020
Q2 | $219K | Buy |
14,876
+2,135
| +17% | +$31.4K | ﹤0.01% | 1344 |
|
|
2020
Q1 | $150K | Buy |
12,741
+1,744
| +16% | +$20.5K | ﹤0.01% | 1370 |
|
|
2019
Q4 | $258K | Sell |
10,997
-14
| -0.1% | -$328 | ﹤0.01% | 1154 |
|
|
2019
Q3 | $204K | Buy |
+11,011
| New | +$204K | ﹤0.01% | 1422 |
|